• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Consumer Cyclical·7731.T
Share

Nikon Corporation Stocks

¥ 1609.5Last Updated 04.11.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

¥ 3.42B

¥ 1609.5
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very poor margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

29.08.2025 12:23

'Kodak moment': Will nostalgia for film be enough to save Kodak?

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Nikon Corporation, a prominent international enterprise established in Tokyo, Japan, in 1917, specializes in the production and distribution of optical instruments. The company maintains a significant global footprint, with operations extending across Japan, North America, Europe, China, Thailand, and other key international markets. Its business activities are organized into three primary segments: Imaging Products, Precision Equipment, and Healthcare. The Imaging Products segment is dedicated to the development, manufacturing, sales, and servicing of a wide range of photographic equipment, including digital SLR cameras, compact digital cameras, and interchangeable lenses. The Precision Equipment segment focuses on providing advanced lithography systems for both flat panel displays (FPD) and semiconductor fabrication. Within the Healthcare segment, Nikon offers essential tools such as biological microscopes, systems for observing cell cultures, and state-of-the-art ultra-wide field retinal imaging devices. Beyond these core divisions, Nikon's extensive product portfolio encompasses industrial microscopes, various measuring instruments like non-contact 3D metrology systems and X-ray/CT inspection systems, and surveying equipment. The company further supplies customized products, optical glass, encoders, and ophthalmic lenses. Additional offerings include photomask substrates, camera components, sport optics products, and molded optical glasses. Moreover, Nikon is actively involved in the development and support of computer software.

Company Valuation

Slightly undervalued
5/7

Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBIT

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of 7731.T is 1702 and suggests 0.479% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommenda

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

04.11.2026 21:27

McDonald's sales in the U.S. fell for the first time in a year and a half due to the failure of its affordable menu

04.11.2026 21:02

CoreWeave bonds fell after opponents of data centers won the U.S. election

04.11.2026 20:27

A Democratic victory is seen as bad news for AI stocks. Why does Goldman Sachs disagree?

04.11.2026 19:43

"Markets Love Political Deadlocks": U.S. Stocks Rise at the Open Following the Election

04.11.2026 19:25

Sales of weight-loss pills exceeded forecasts by 20%. Will Novo reclaim the lead from Lilly?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026